UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000004148 |
|---|---|
| Receipt number | R000004979 |
| Scientific Title | Phase II study of Neoadjuvant chemotherapy with Gemcitabine and S1 for resectable pancreatic carcinoma |
| Date of disclosure of the study information | 2010/10/01 |
| Last modified on | 2017/09/07 09:10:16 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2010/09/02 10:16:45 | ||
| 2 | Update | 2010/11/04 09:17:09 | Recruitment status |
|
| 3 | Update | 2011/09/04 08:51:55 | Post marketing survey by drug manufacture etc., specified by Japanese law. |
|
| 4 | Update | 2012/10/20 08:53:57 | Recruitment status |
|
| 5 | Update | 2013/03/04 17:09:18 | Email |
|
| 6 | Update | 2014/03/03 12:23:38 | TEL |
|
| 7 | Update | 2014/10/02 10:20:02 | Organization1 Tel1 Email1 Organization2 Address2 Tel2 Email2 |
|
| 8 | Update | 2017/09/07 09:09:21 | Name of primary person or sponsor Organization |
|
| 9 | Update | 2017/09/07 09:10:16 | Recruitment status |
